A detailed history of Golden State Equity Partners transactions in Johnson & Johnson stock. As of the latest transaction made, Golden State Equity Partners holds 3,399 shares of JNJ stock, worth $527,422. This represents 0.3% of its overall portfolio holdings.

Number of Shares
3,399
Previous 13,937 75.61%
Holding current value
$527,422
Previous $2.26 Million 75.64%
% of portfolio
0.3%
Previous 0.51%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$145.48 - $167.38 $1.53 Million - $1.76 Million
-10,538 Reduced 75.61%
3,399 $550,000
Q3 2024

Oct 25, 2024

SELL
$145.48 - $167.38 $143,879 - $165,538
-989 Reduced 6.63%
13,937 $2.26 Million
Q2 2024

Jul 29, 2024

SELL
$144.38 - $157.78 $620,689 - $678,296
-4,299 Reduced 22.36%
14,926 $2.18 Million
Q4 2023

Feb 02, 2024

SELL
$145.6 - $158.88 $732,368 - $799,166
-5,030 Reduced 20.74%
19,225 $3.01 Million
Q3 2023

Oct 20, 2023

BUY
$155.75 - $174.48 $102,639 - $114,982
659 Added 2.79%
24,255 $3.78 Million
Q2 2023

Jul 19, 2023

SELL
$154.35 - $166.11 $310,860 - $334,545
-2,014 Reduced 7.86%
23,596 $3.91 Million
Q1 2023

Jun 01, 2023

BUY
$151.05 - $180.26 $1.21 Million - $1.45 Million
8,028 Added 45.66%
25,610 $3.97 Billion
Q1 2022

May 18, 2022

BUY
$158.14 - $179.59 $391,870 - $445,024
2,478 Added 16.41%
17,582 $3.12 Million
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $726,969 - $825,575
-4,597 Reduced 23.33%
15,104 $2.48 Million
Q4 2021

Feb 11, 2022

SELL
$155.93 - $173.01 $373,608 - $414,531
-2,396 Reduced 10.84%
19,701 $3.37 Million
Q3 2021

Nov 15, 2021

BUY
$161.5 - $179.47 $485,469 - $539,486
3,006 Added 15.75%
22,097 $3.57 Million
Q2 2021

Aug 12, 2021

BUY
$159.48 - $171.07 $635,846 - $682,056
3,987 Added 26.4%
19,091 $3.15 Million
Q1 2021

May 13, 2021

BUY
$153.07 - $170.48 $220,573 - $245,661
1,441 Added 10.55%
15,104 $2.48 Million
Q4 2020

Feb 08, 2021

BUY
$137.11 - $157.38 $1.87 Million - $2.15 Million
13,663 New
13,663 $2.15 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Golden State Equity Partners Portfolio

Follow Golden State Equity Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Golden State Equity Partners, based on Form 13F filings with the SEC.

News

Stay updated on Golden State Equity Partners with notifications on news.